Skip to main content

23 August 2026

Last updated: Thursday 20 August 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Build-to-buy model attracts Pharma investors

Tuesday 26 August 2014

Interviewee/Contributor

Clare Ozawa

Organisation

Inception Sciences Inc

Organisations

Arecor Therapeutics Plc
Pharming Group NV
Novo Nordisk Foundation
Zelluna Immunotherapy AS
NDA Group AB
University of Medicine and Dentistry of New Jersey
Merus B.V.
Terumo Blood and Cell Technologies
European Confederation of Pharmaceutical Entrepreneurs
Karolinska Institutet

Interviewees and Contributers

Malcolm Weir
Femida Gwadry-Sridhar
Gregg Sando
Todd Sherer
Darrin Disley
Matthias Heck
Carl June
Jónas Einarsson
Adam Steensberg
Emanuel Björne

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

ViCentra appoints CFO and adds a board member

Wednesday 22 July 2026

New CEO at Simris Biologics

Wednesday 22 July 2026

New CEO at Genopore

Wednesday 22 July 2026

Camena Bioscience appoints CEO

Wednesday 22 July 2026

Lundbeck promotes research head to EVP R&D

Wednesday 22 July 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form